1. Home
  2. ALAR vs GDTC Comparison

ALAR vs GDTC Comparison

Compare ALAR & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

N/A

Current Price

$1.66

Market Cap

13.3M

Sector

Technology

ML Signal

N/A

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.94

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
GDTC
Founded
2013
2018
Country
Israel
Singapore
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
10.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ALAR
GDTC
Price
$1.66
$0.94
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
108.3K
49.6K
Earning Date
05-28-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.51
N/A
Revenue Next Year
$33.43
N/A
P/E Ratio
$44.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.62
$0.68
52 Week High
$18.00
$3.68

Technical Indicators

Market Signals
Indicator
ALAR
GDTC
Relative Strength Index (RSI) 24.64 N/A
Support Level $1.62 N/A
Resistance Level $2.10 N/A
Average True Range (ATR) 0.09 0.00
MACD 0.14 0.00
Stochastic Oscillator 9.09 0.00

Price Performance

Historical Comparison
ALAR
GDTC

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: